AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-135661487/celebrex-gets-another-indication.html" title="Facts and information about Celebrex gets another indication.(Pfizer Inc. gets approval)(Brief Article)">Celebrex gets another indication.(Pfizer Inc. gets approval)(Brief Article)</a>

Close Set up an RSS feed that alerts you when new articles from Mass Market Retailers are available.

Frequently asked questions about RSS feeds

Celebrex gets another indication.(Pfizer Inc. gets approval)(Brief Article)

Mass Market Retailers

| August 22, 2005 | COPYRIGHT 2009 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

NEW YORK -- The Food and Drug Administration has approved the use of Pfizer Inc.'s Celebrex to treat symptoms of ankylosing spondylitis, a form of arthritis that affects the spine. The drug has heretofore been used to combat the pain of osteo arthritis and adult rheumatoid arthritis, acute pain and menstrual pain.

The FDA also finalized the label instructions for all approved uses, including additional warnings about potential cardiovascular and gastrointestinal risks. Similar warnings will be required for such over-the-counter analgesics as ibuprofen and naproxen.

Ankylosing spondylitis affects over 400,000 Americans, usually striking people ages 17 to 35 in…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


FDA Approves New Use for Pfizer's Celebrex; Finalizes Prescribing Information,...: Press release article from: PR Newswire August 1, 2005 700+ words
...FirstCall/ -- Pfizer Inc said today...associated with ankylosing spondylitis, a form of...arthritis, ankylosing spondylitis also can cause...Joseph Feczko, Pfizer's chief...associated with ankylosing spondylitis can cause...


FDA approves new use for Pfizer's Celebrex; finalizes prescribing information,...: News wire article from: Asia Africa Intelligence Wire August 1, 2005 700+ words
...Business NewsBase - Press Release) Pfizer Inc said that the US Food and Drug Administration...the signs and symptoms associated with ankylosing spondylitis, a form of arthritis that affects the...for familial adenomatous polyposis. Pfizer has accumulated extensive clinical data...


Thoracic high resolution computed tomography in patients with ankylosing...: Magazine article from: Annals of the Rheumatic Diseases El Maghraoui, A Chaouir, S Bezza, A Tabache, F Abouzahir, A Ghafir, D Ohayon, V Archane, MI February 1, 2003 700+ words
...pleuropulmonary disease in ankylosing spondylitis (AS) varies from...by a grant from Pfizer. REFERENCES (1) Davies D. Ankylosing spondylitis and lung fibrosis...manifestations of ankylosing spondylitis. J Rheumatol 1975...


Celecoxib gains AS indication, but new warning.(ankylosing spondylitis ): Magazine article from: Internal Medicine News Ault, Alicia September 15, 2005 700+ words
...increased risk of cardiovascular events. The Pfizer Inc. drug was approved for ankylosing spondylitis (AS), a connective tissue disorder causing...be titrated to 400 mg daily, according to Pfizer. If there is still no response after 6 weeks...


Celecoxib gets new indication, new warning: drug is now approved for ankylosing...: Magazine article from: Clinical Psychiatry News Ault, Alicia October 1, 2005 700+ words
...increased risk of cardiovascular events. The Pfizer Inc. drug was approved for ankylosing spondylitis (AS), a connective tissue disorder causing...be titrated to 400 mg daily, according to Pfizer. If there is still no response after 6 weeks...


NEW INVESTIGATIONAL STUDY DATA DESCRIBES EFFICACY OF CELEBREX IN PATIENTS WITH...: Press release article from: PR Newswire October 31, 2000 700+ words
...Pharmacia and Pfizer's COX...patients who have ankylosing spondylitis (AS)1...inflammation of Ankylosing Spondylitis (AS), which...BASFI, Bath Ankylosing Spondylitis Functional...Pharmacia and Pfizer including...


New Investigational Study Data Describe Efficacy of Celebrex(R) in Patients...: Press release article from: PR Newswire October 30, 2000 700+ words
...PHA) and Pfizer's COX...patients who have ankylosing spondylitis (AS)(1...inflammation of Ankylosing Spondylitis (AS), which...BASFI, Bath Ankylosing Spondylitis Functional...Pharmacia and Pfizer including...


PRESS RELEASE: New investigational study data describe efficacy of Celebrex in...: News wire article from: Chemical Business Newsbase November 8, 2000 700+ words
...ACR) showed that Pharmacia and Pfizer's COX-2 specific inhibitor...function in patients who have ankylosing spondylitis (AS), a painful and debilitating...symposium sponsored by Pharmacia and Pfizer including a head-to-head study...


Ankylosing Spondylitis: How Have Biological Therapies Affected the Market?: Press release article from: M2 Presswire April 14, 2009 700+ words
...increase in the ankylosing spondylitis (AS) market from...Emerging Therapies for Ankylosing Spondylitis -2007 Market and...Bibliography - Ankylosing Spondylitis -Tables Companies...Novartis - Ovation - Pfizer - Pozen - Procter...


Research and Markets: Ankylosing Spondylitis: How Have Biological Therapies...: Press release article from: Business Wire April 14, 2009 700+ words
...increase in the ankylosing spondylitis (AS) market from...Emerging Therapies for Ankylosing Spondylitis * 2007 Market and...Bibliography - Ankylosing Spondylitis * Tables Companies...Novartis * Ovation * Pfizer * Pozen * Procter...

For more facts and information, see all results

Source: HighBeam Research, Celebrex gets another indication.(Pfizer Inc. gets approval)(Brief...

The AccessMyLibrary advertising network includes: